22:36
1
PINAI SERIES: Precision medicine in practice - diagnostic algorithms & geroncology
Presentation by Dr. Evelyne Yehudit Bischof
CLINICAL IMPACT Series
CLINICAL IMPACT SERIES: SABCS 2021 - Adjuvant Breast Cancer for ER+ HER2-, and ER-
AI Series
AI SERIES - Precision medicine cancer therapeutics, HR sensitive BC and AI challenges
AI Series
AI SERIES - Precision medicine cancer therapeutics, HR sensitive BC and AI challenges
Presentation by Pr. John Robertson MD
AI SERIES - AI assisted drug development and repurposing in Breast Cancer
With Dr. Evelyne Yehudit Bischof
AI SERIES - Personalized vs precision medicine, clinical applicability
Presentation by Dr. Evelyne Yehudit Bischof
AI SERIES - Do we need Artificial Intelligence for Precision Medicine?
Presentation by Pr. Robert Clarke Ph.D., D.Sc.
CLINICAL IMPACT Series
CLINICAL IMPACT SERIES: SABCS 2021 - Metastatic Breast Cancer
Presentations review with Dr. Jamil Asselah, MD, FRCPC
CLINICAL IMPACT SERIES: SABCS 2021 - Neo Adjuvant Breast Cancer
Presentations review with Dr. Rami Younan, MD, FRCSC
CLINICAL IMPACT SERIES: SABCS 2021 - Adjuvant Breast Cancer for ER+ HER2-, and ER-
Presentations review with Dr. Jean-Pierre Ayoub, MD, FRCPC
COVID Impact
ESMO-2020 - Expected medium and long-term impact of the COVID-19 outbreak in Oncology
Presentation by Professor Guy Jerusalem
A Global Collaborative study looking at the Impact of COVID-19 Pandemic on Cancer Care
With Dr. Abdul-Rahman Jazieh
COVID-19 pandemic and Changes in Breast Cancer Management in the UK
With Professor John Robertson
OICR Series
Predicting Response to Anthracyclines
Presentation by Dr. Melanie Spears, PhD
Congress programs
Characterization of immune “hot” hormone receptor positive breast cancer
Presentation by Dr. Melanie Spears
ESMO-2020 - Adjuvant abemaciclib reduces relapse risk in high-risk early breast cancer (MonarchE)
Presentation by Professor Stephen Johnston
Targeting novel pathways in breast cancer
With Jorge S Reis-Filho, MD PhD FRCPath
LBA8 KEYNOTE-522 study and the LBA9 Phase 3 BROCADE study
Late breaking abstracts discussion:
Multidisciplinary management of germline and somatic gene alterations in patients with metastatic breast cancer.
With Dr. Judith Balmaña
HER2 overexpressing breast cancer
Novel therapeutic strategies
What’s needed next to meet the challenges in ER+ve breast cancer care?
A researcher perspective
HER2 Positive Breast Cancer: A Clinical Update since the St. Gallen International Breast Conference in 2017
with Martine J. Piccart, MD, PhD
New Insights in Luminal Breast Cancer
with Matthew J. Ellis, MB, BChir, BSc, PhD
Targeting Immune Pathways in Breast Cancer
with Sherene Loi, MD, PhD
ASCO 2022
The success of ADCs raises questions about patient selection
Scientific Presentation with Prof. John Bartlett reviewing the current data on how the success of ADCs raises questions about patient selection
All Programs
The success of ADCs raises questions about patient selection
Scientific Presentation with Prof. John Bartlett reviewing the current data on how the success of ADCs raises questions about patient selection
Predicting Response to Anthracyclines
Presentation by Dr. Melanie Spears, PhD
CLINICAL IMPACT SERIES: SABCS 2021 - Metastatic Breast Cancer
Presentations review with Dr. Jamil Asselah, MD, FRCPC
CLINICAL IMPACT SERIES: SABCS 2021 - Neo Adjuvant Breast Cancer
Presentations review with Dr. Rami Younan, MD, FRCSC
CLINICAL IMPACT SERIES: SABCS 2021 - Adjuvant Breast Cancer for ER+ HER2-, and ER-
Presentations review with Dr. Jean-Pierre Ayoub, MD, FRCPC
AI SERIES: Precision medicine in practice - diagnostic algorithms & geroncology
Presentation by Dr. Evelyne Yehudit Bischof
AI SERIES - Precision medicine cancer therapeutics, HR sensitive BC and AI challenges
Presentation by Pr. John Robertson MD
AI SERIES - AI assisted drug development and repurposing in Breast Cancer
With Dr. Evelyne Yehudit Bischof
AI SERIES - Personalized vs precision medicine, clinical applicability
Presentation by Dr. Evelyne Yehudit Bischof
AI SERIES - Do we need Artificial Intelligence for Precision Medicine?
Presentation by Pr. Robert Clarke Ph.D., D.Sc.
Characterization of immune “hot” hormone receptor positive breast cancer
Presentation by Dr. Melanie Spears
ESMO-2020 - Expected medium and long-term impact of the COVID-19 outbreak in Oncology
Presentation by Professor Guy Jerusalem
A Global Collaborative study looking at the Impact of COVID-19 Pandemic on Cancer Care
With Dr. Abdul-Rahman Jazieh
ESMO-2020 - Adjuvant abemaciclib reduces relapse risk in high-risk early breast cancer (MonarchE)
Presentation by Professor Stephen Johnston
COVID-19 pandemic and Changes in Breast Cancer Management in the UK
With Professor John Robertson
Targeting novel pathways in breast cancer
With Jorge S Reis-Filho, MD PhD FRCPath
LBA8 KEYNOTE-522 study and the LBA9 Phase 3 BROCADE study
Late breaking abstracts discussion:
Multidisciplinary management of germline and somatic gene alterations in patients with metastatic breast cancer.
With Dr. Judith Balmaña
HER2 overexpressing breast cancer
Novel therapeutic strategies
What’s needed next to meet the challenges in ER+ve breast cancer care?
A researcher perspective
Educational Presentation summarizing “Neoadjuvant vs adjuvant approaches in early TNBC”
With Javier Cortes, MD PhD
Using integrated OMICS and deep targeted sequencing as novel diagnostic processes in cancer
with John Bartlett, Ph.D, FRCPath
HER2 Positive Breast Cancer: A Clinical Update since the St. Gallen International Breast Conference in 2017
with Martine J. Piccart, MD, PhD
New Insights in Luminal Breast Cancer
with Matthew J. Ellis, MB, BChir, BSc, PhD
Targeting Immune Pathways in Breast Cancer
with Sherene Loi, MD, PhD